Centers for Disease Control and Prevention (HQ)

Adult Flu Vaccines 2023-2024

Last update: Dec 23, 2022 Last update: 23 Dec, 2022

Details

Location:USAUSA
Category:Goods
Status:Awarded
Sectors:Health
Contracting Authority Type:Development Institution
Eligibility:Organisation
Budget:N/A
Date posted:28 Sep, 2022

Attachments 6

Associated Awards

Project cycle timeline

STAGES
EARLY INTELLIGENCE
PROCUREMENT
IMPLEMENTATION
Cancelled
Status
Programming
Formulation
Approval
Forecast
Open
Closed
Shortlisted
Awarded
Evaluation

Associated tenders 0

Status

Date

Description

Notice ID
75D301-22-R-72412
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
CENTERS FOR DISEASE CONTROL AND PREVENTION
Office
CDC OFFICE OF ACQUISITION SERVICES
 
 

General Information

  • Contract Opportunity Type: Combined Synopsis/Solicitation (Original)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Sep 27, 2022 02:06 pm EDT
  • Original Date Offers Due: Oct 11, 2022 05:00 pm EDT
  • Inactive Policy: 15 days after date offers due
  • Original Inactive Date: Oct 26, 2022
  • Initiative:
    • None
 

Classification

  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
     
    USA
 

Description

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following adult vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:
Item Descriptions and Quantities:
Influenza Vaccine – Adult (age 19 years and older)
Min. Order Size: 100 Doses
Fed. Excise Tax: $0.75 per dose
Maximum: 20,000,000 Doses
Minimum: 100 Doses

Provide age indication and NDC for any vaccines proposed.
Proposed Quantity and Presentation: Offerors may propose any number of vaccines or presentations of influenza vaccine (IV).
The vaccines awarded under the resulting contracts will be purchased for and by NCIRD's immunization awardees to support adult immunization programs as provided under Section 317(j) of the Public Health Service ActVaccines shall be delivered F.O.B. Destination to the CDC centralized distribution locations currently in Aurora, CO and Memphis, TN. In addition, shipments to five CDC Occupational Health Clinic locations may be requested by the CDC. The period of performance shall be from the date of award through February 28, 2024. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.sam.gov when issued. No hard copies of the solicitation and amendments will be mailed. Please note funds are not currently available for the award. This solicitation is subject of funds availability during FY 2023. Any questions regarding this notice shall be submitted in writing ONLY to Brian Swann at qty0@cdc.gov and Pellumbeshe Hoxhaj at kfx2@cdc.gov. Telephone inquiries will not be honored.

 
 
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 112+ donors and banks are available here
Learn more about our membership benefits